With dutasteride as its active ingredient, Dutanol 0.5mg is formulated around a 0.5mg oral dose. Dutasteride inhibits both major forms of 5-alpha-reductase, reducing the formation of dihydrotestosterone within the body. This mechanism is relevant to therapies involving benign prostatic hyperplasia and, in some clinical settings, androgen-related hair loss.

The strength should be understood as a specific medical dose rather than a general indication for self-treatment. Dutasteride can affect hormone-related measurements and may require ongoing clinical assessment during treatment. Use should therefore follow the dosage and monitoring instructions provided by a healthcare professional.